Postprandial peaking and plateauing of triglycerides and VLDL in patients with underlying cardiovascular diseases despite treatment

International Journal of Endocrinology and Metabolism

Volumn 10, Issue 4, 2012, Pages 587-593

  Samson, Clarissa E ^a   Galia, Ana Lyza B ^a   Llave, Khristine Ivy C ^a   Zacarias, Manuel B ^a   Mercado Asis, Leilani B ^a  

^a UNIVERSITY OF SANTO TOMAS HOSPITAL   (Philippines)

Author keywords

Cardiovasular disease; Postprandial lipemia; Triglyceride; VLDL

Indexed keywords

ATORVASTATIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; ROSUVASTATIN; SIMVASTATIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RESPONSE; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIET RESTRICTION; FEMALE; HIGH RISK PATIENT; HUMAN; HYPERLIPIDEMIA; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; LOW FAT DIET; MALE; POSTPRANDIAL STATE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84872516435     PISSN: 1726913X     EISSN: 17269148     Source Type: Journal    
DOI: 10.5812/ijem.4783     Document Type: Article

References (33)

1. Dans AL, Morales DD, Velandria FV, Abola MTB, Roxas Jr A, Punzalan FER, et al. National Nutrition and Health Survey (NNHeS): atherosclerosis-related diseases and risk factors. PJC. 2005;33(2).
2. Kadar A, Glasz T. Development of atherosclerosis and plaque biology. Cardiovasc Surg. 2001;9(2):109-21.
3. Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA. 2007;298(3):309-16.
4. Klop B, Proctor SD, Mamo JC, Botham KM, Castro Cabezas M. Understanding postprandial inflammation and its relationship to lifestyle behaviour and metabolic diseases. Int J Vasc Med.2012;2012:947417.
5. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts). Eur Heart J. 2007;28(19):2375-414.
6. Proctor SD, Vine DF, Mamo JC. Arterial retention of apolipoprotein B(48)- and B(100)-containing lipoproteins in atherogenesis. Curr Opin Lipidol. 2002;13(5):461-70.
7. Zilversmit DB. Atherogenesis: a postprandial phenomenon. Circulation. 1979;60(3):473-85.
8. Pal S, Semorine K, Watts GF, Mamo J. Identification of lipoproteins of intestinal origin in human atherosclerotic plaque. Clin Chem Lab Med. 2003;41(6):792-5.
9. Rapp JH, Lespine A, Hamilton RL, Colyvas N, Chaumeton AH, Tweedie-Hardman J, et al. Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque. Arterioscler Thromb. 1994;14(11):1767-74.
10. Bravo E, Napolitano M, Botham KM. Postprandial lipid metabolism: the missing link between life-style habits and the increasing incidence of metabolic diseases in western countries? Open Trans Med J. 2010;2:1-13.
11. Boquist S, Ruotolo G, Tang R, Bjorkegren J, Bond MG, de Faire U, et al. Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intima-media thickness in healthy, middle-aged men. Circulation. 1999;100(7):723-8.
12. Hyson D, Rutledge JC, Berglund L. Postprandial lipemia and cardiovascular disease. Curr Atheroscler Rep. 2003;5(6):437-44.
13. Maggi FM, Raselli S, Grigore L, Redaelli L, Fantappie S, Catapano AL. Lipoprotein remnants and endothelial dysfunction in the postprandial phase. J Clin Endocrinol Metab. 2004;89(6):2946-50.
14. Phillips LK, Peake JM, Zhang X, Hickman IJ, Kolade O, Sacre JW, et al. The effect of a high-fat meal on postprandial arterial stiffness in men with obesity and type 2 diabetes. J Clin Endocrinol Metab. 2010;95(9):4455-9.
15. Buring J, Hennekens C. The Women's Health Study: summary of the study design. J Myocardial Ischemia. 1992;4(3):27-9.
16. Daugherty A, Lange LG, Sobel BE, Schonfeld G. Aortic accumulation and plasma clearance of beta-VLDL and HDL: effects of diet-induced hypercholesterolemia in rabbits. J Lipid Res. 1985;26(8):955-63.
17. Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med. 2005;352(13):1293-304.
18. Cohn JS. Postprandial lipemia: emerging evidence for atherogenicity of remnant lipoproteins. Can J Cardiol. 1998;14 Suppl B:18B-27B.
19. Lundman P, Eriksson M, Schenck-Gustafsson K, Karpe F, Tornvall P. Transient triglyceridemia decreases vascular reactivity in young, healthy men without risk factors for coronary heart disease. Circulation. 1997;96(10):3266-8.
20. So T, Mercado-Asis L, Zacarias M. A Comparison Of Dose Response Postprandial Lipid Profile Of Healthy Filipino Subjects After An Oral Fat Challenge Test Of Varying Fat Contents. Phill J Internal Medicine. 2004;42:1-7.
21. Gabriel FS, Samson CE, Abejuela ZR, Sicat-Gabriel PR, Sumpio JP, Zacarias MB, et al. Postprandial Effect of Orlistat on the Peaking of Lipid Level After Sequential High Fat Meals. Int J Endocrinol Metab. 2012;10(2):458-63.
22. Detection EPO. Evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of The National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-97.
23. Ginsberg HN. New perspectives on atherogenesis: role of abnormal triglyceride-rich lipoprotein metabolism. Circulation. 2002;106(16):2137-42.
24. Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA. 2007;298(3):299-308.
25. Kolovou GD, Daskalova D, Iraklianou SA, Adamopoulou EN, Pilatis ND, Hatzigeorgiou GC, et al. Postprandial lipemia in hypertension. J Am Coll Nutr. 2003;22(1):80-7.
26. Patsch JR, Miesenbock G, Hopferwieser T, Muhlberger V, Knapp E, Dunn JK, et al. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb. 1992;12(11):1336-45.
27. Przybycien K, Kornacewicz-Jach Z, Torbus-Lisiecka B, Naruszewicz M. Is abnormal postprandial lipemia a familial risk factor for coronary artery disease in individuals with normal fasting concentrations of triglycerides and cholesterol? Coron Artery Dis. 2000;11(5):377-81.
28. Sharrett AR, Heiss G, Chambless LE, Boerwinkle E, Coady SA, Folsom AR, et al. Metabolic and lifestyle determinants of postprandial lipemia differ from those of fasting triglycerides: The Atherosclerosis Risk In Communities (ARIC) study. Arterioscler Thromb Vasc Biol. 2001;21(2):275-81.
29. Boccalandro F, Farias J, Boccalandro C, Vaisman D. Frequency of postprandial lipemia after a first acute coronary event (unstable angina pectoris or non-ST-segment elevation acute myocardial infarction) and the effects of atenolol on the lipemia. Am J Cardiol. 2002;90(2):153-6.
30. Pastromas S, Terzi AB, Tousoulis D, Koulouris S. Postprandial lipemia: an under-recognized atherogenic factor in patients with diabetes mellitus. Int J Cardiol. 2008;126(1):3-12.
31. Simpson HS, Williamson CM, Olivecrona T, Pringle S, Maclean J, Lorimer AR, et al. Postprandial lipemia, fenofibrate and coronary artery disease. Atherosclerosis. 1990;85(2-3):193-202.
32. Abejuela ZR, Macaballug AG, Sumpio JP, Zacarias MB, Mercado LB. Orlistat abolishes postprandial peaking. Int J Endocrinol Metab. 2009;7(3):179-86.
33. Litonjua A, Sy RA. Lipid Lowering Effect of Orlistat Beyond Weight Reduction in Overweight/Obese Filipino Patients: An RCT Study. PJIM. 2004;42:297-305.